Baudax BioInc exotic insider transaction detected

BXRXDelisted Stock  USD 0.76  0.06  7.32%   
Slightly above 62% of Baudax Bio's investor base is looking to short. The analysis of current outlook of investing in Baudax Bio suggests that many traders are alarmed regarding Baudax Bio's prospects. Baudax Bio's investing sentiment can be driven by a variety of factors including economic data, Baudax Bio's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Baudax Bio Inc director. Unconventional Insider trading

Read at macroaxis.com
Baudax insider trading alert for general transaction of common stock by Kim Yong Chan, the corporate stakeholder, on 13th of July 2023. This event was filed by Baudax Bio Inc with SEC on 2023-07-13. Initial filing of beneficial ownership - SEC Form 3

Baudax Bio Fundamental Analysis

We analyze Baudax Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baudax Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baudax Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

Baudax Bio is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Baudax Bio Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baudax Bio stock to make a market-neutral strategy. Peer analysis of Baudax Bio could also be used in its relative valuation, which is a method of valuing Baudax Bio by comparing valuation metrics with similar companies.

Peers

Baudax Bio Related Equities

ENSCEnsysce Biosciences   14.58   
0%
100.0%
WINTWindtree Therapeutics   12.00   
0%
82.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
11.0%
PALIPalisade Bio   0.83   
0%
5.0%
CYTOAltamira Therapeutics   2.33   
15.0%
0%
NRBONeurobo Pharmaceuticals   2.89   
19.0%
0%
ALLRAllarity Therapeutics   3.13   
21.0%
0%
BDRXBiodexa Pharmaceticals   3.61   
24.0%
0%
VRAXVirax Biolabs   4.27   
29.0%
0%
DRMADermata Therapeutics   4.35   
29.0%
0%
CNSPCns Pharmaceuticals   7.69   
52.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Baudax Stock

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation